Household & Personal Products
49 recent notes from companies in this sector. 20 companies tracked.
Dabur flags double-digit Q1 revenue growth, price actions cushion inflation
Voluntary update ahead of July 29 results: India FMCG near double-digit, international high-teens, PAT also seen double-digit as price actions offset input costs.
Stanley Lifestyles opens first Sri Lanka boutique with Singer
The 7,350 sq ft store in Colombo is a new geography for the micro-cap, but the filing discloses no investment or revenue expectations.
Godrej Consumer Q1 growth hits high-teens, beats full-year target
High-teens consolidated revenue in Q1 FY27, broad-based across India, Indonesia, and Africa. Input costs easing; margin recovery on track.
Aarti Surfactants' preference redemption costs 20x more than flagged
Board approves ₹167.70 per share including premium and return, versus earlier intimation of only face value. Total payout of ₹23 crore is 7.2% of market cap.
Cupid lifts FY27 revenue guidance to ₹660+ cr after Q1 tops ₹150 cr
First quarter one of strongest in history; management raises full-year target by at least 10% on international demand and new PFSCM supply deal.
Milestone Furniture delays FY26 results after director's brain haemorrhage
The nano-cap's whole-time director is incapacitated; results delayed indefinitely. For a company with ₹25 cr market cap, this is a material governance risk.
Jyothy Labs was talking up Pril while quietly killing it
Management told investors in May they'd keep investing in Pril. By June 1, manufacturing stopped. Arbitration at SIAC has begun.
Gillette India shines on Guard 3-in-1 launch, margin gains
FY26 revenue up 8%, profit up 23%, structural margin improvement of 300+ bps. Guard 3-in-1 sold 1M razors in first month. Management cautious on commodities, no FY27 guidance.
Jyothy Labs sues Henkel over Pril and Fa brand license expiry
The board approved litigation to enforce exit and transition mechanisms after Henkel declined to renew the 15-year license agreements that expired May 31.
Lykis board proposes ₹200 cr investment limit, dwarfing its ₹89 cr market cap
The nano-cap firm also approves borrowings up to ₹100 cr, names new chairman, and seeks a name change to Krowniq. All major proposals need shareholder nod.
Dabur gets US FDA import alert — but only for minuscule revenue slice
The Silvassa plant is under an Import Alert for data integrity issues, but Dabur says the affected products generate 'insignificant revenue'. Domestic business is untouched.
Recode Studios' earnings call transcript adds no new information
The full transcript of the June 3 call provides operational detail but rehashes the guidance and results already disclosed in the audited results and prior summary.
Inflame targets 50% revenue growth, bets on making its own motors.
FY27 chimney production is set to hit 400,000 units. The company is using a 34%-held associate to build key components.
Cello's writing instruments jumped 64%. Glassware stayed at breakeven.
One segment is carrying the company. Chinese dumping has the other stuck. FY27 guidance is 10-12% revenue growth and ₹100 cr in capex.
Recode tripling profit isn't the story. Its delivery pivot is.
FY26 profit tripled to ₹11.22 cr on 67% revenue growth. But the bigger news is a high-risk bet on owned delivery and contradictory sales data.
Recode Studios corrects its annual accounts. The full-year profit moves by 0.12%.
A H2 expense misallocation pushed second-half profit up **29.4%**, but the annual PAT barely budged, rising from **₹1,121.12 lakh** to **₹1,122.48 lakh**.
Inflame chases ₹10,000 cr in orders. Its market cap is ₹176 cr.
A nano-cap pivots from kitchen appliances to roads and mines. Margins are being squeezed to win the work, and a ₹1,450 cr government bill is still unpaid.
Sarup Industries' profit drops to ₹57 lakh, but last year had a one-off
The headline fall is an accounting artefact. Strip out the prior-year exceptional item, and profit is roughly flat.
Anondita Medicare targets ₹1,000 cr revenue in two years
Management plans to scale female condom production to 240 million units by FY27, backed by a 78.5% revenue jump in FY26.
Carysil's Q4 transcript offers no surprises
The latest earnings call transcript confirms existing guidance and expansion plans, adding no new material information.
Gillette India shuffles finance leadership in planned succession
The company appointed a new CFO as part of a routine leadership transition, while the outgoing finance chief moves into a senior VP role.
Gillette India posts ₹3,099.53 cr revenue for FY26
The board recommended a final dividend of ₹60 per share, following an interim dividend of ₹180 per share.
JHS Svendgaard narrows annual losses as revenue climbs to ₹10,169.47 lakhs
The oral care manufacturer cut its annual net loss to ₹191.73 lakhs for FY26, though a fourth-quarter loss of ₹356.56 lakhs keeps the company in the red.
JHS Svendgaard narrows annual losses to ₹191.73 lakhs
The company trimmed its standalone net loss from ₹1,973.84 lakhs in FY25 to ₹191.73 lakhs for the year ended March 31, 2026.
VIP Industries refreshes board with two new independent directors
The company replaced two outgoing independent directors, including its audit committee chair, with senior executives from Reckitt and Trent.
Shashwat Furnishing Solutions swings to loss as standalone revenue halves
The company reported a standalone net loss of ₹53.76 lakh for FY26, down from a profit of ₹35.59 lakh, while consolidated losses persist despite a recent acquisition.
Shashwat Furnishing swings to loss as standalone revenue halves
The company reported a standalone net loss of ₹53.8 lakh for FY26, a sharp reversal from the prior year's profit of ₹35.6 lakh.
Thrive Future Habitats loss widens to ₹97 lakhs as revenue shrinks
A ₹44.66 crore preferential issue wiped out all debt and left the company with over ₹22 crore in cash, but operations shrank badly.
Thrive Future Habitats raises ₹44.66 cr as revenue halves
A preferential share issuance has flooded the nano-cap with cash, erasing all debt even as its core business contracts sharply.
Thrive raised ₹22 cr to wipe debt. The business it's funding just lost more money.
A preferential equity issuance transformed the balance sheet, but revenue fell 44% and the net loss deepened in FY26.
Emami's Q4 call transcript adds no new numbers beyond the May 21 concall.
A routine disclosure; the forward-looking guidance on summer brands and international recovery was already in the concall summary.
Lykis MD quits after change of control, adding to a boardroom shake-up
Nadir Dhrolia, the managing director, stepped down effective June 1. He is the third senior exit since the company changed hands.
Colgate-Palmolive India's routine recap adds nothing new
A newsletter summarizing already-disclosed Q4 results and a dividend of ₹24 per share.
Colgate-Palmolive India misses margin targets and skips forward guidance
Full-year EBITDA margins landed at 31.2%, falling short of the 32-34% target. Management now declines to provide specific margin projections.
Colgate-Palmolive (India) approves FY26 results, ₹24 dividend, CFO reappointment
The board's stamp was procedural. The underlying numbers, dividend, and CFO appointment were already disclosed.
Colgate-Palmolive India grows 9% in Q4 as total dividend reaches ₹48
The FMCG firm closes a flat year with a rebound in the final quarter and a second interim dividend payment.
Colgate India's Q4 sales jump 9%, but the full year stayed flat.
A strong final quarter couldn't offset a year-long GST drag on the topline. The board kept the dividend steady at ₹48 a share.
Wakefit's raw material bill jumped 160%. It will take a margin hit to keep growing.
CEO Ankit Garg said the company will sacrifice 1-2% of EBITDA margin to defend 20% revenue growth. The inflation is real.
Wakefit swings to profit on tax gain, but core earnings story is quieter
A ₹980.7M deferred tax asset drove the Q4 bottom line. Strip that out, and the turnaround is slower than the headline suggests.
Wakefit flips from loss to ₹189 cr profit in FY26
Revenue reached ₹1,488.9 cr as the mattress and home furnishing brand turned its financial performance around.
Wakefit turns profitable, reporting ₹189.2 cr net profit for FY26
The home furnishings retailer moved from a ₹35 cr loss to a profit, while booking a deferred tax asset of ₹103.4 cr to signal future gains.
Carysil's capacity expansion timelines pushed back by 9-12 months
In a concall, management confirmed delays of 9-12 months on quartz sink and appliances capacity, while reaffirming revenue and margin guidance.
Emami eyes double-digit summer growth, 30% lift in strategic bets
Management's H1 FY27 outlook sees summer brands recovering, international business stabilising, and a portfolio of newer bets targeting 30% growth.
Galaxy Surfactants guides Q1 volume growth to upper end of 6-8% range
Management sees EBITDA per tonne between ₹19,000-21,000 for the June quarter; India grows 8%, AMET contracts 15%.
Emami's Q4 results: no new news in investor presentation
Management reiterates resilience in non-summer portfolio, but seasonal headwinds and geopolitical issues weighed on Q4.
Emami's Q4 revenue drops 4% on summer drag; non-summer portfolio up 11%
Unfavourable weather and geopolitical disruptions hit quarterly performance, but the core non-summer portfolio shows resilience.
Emami's audited results show modest profit dip in Q4, FY26
Consolidated PAT down ~11.7% for Q4, ~3.4% for full year. Governance resolutions pass as routine.
Emami's Q4 PAT dips ~12% in routine earnings release
Audited standalone and consolidated numbers for FY26 show a mild dip, while the board reappoints the MD for a second term; no guidance revision or strategic surprise.
Emami's FY26 revenue and profit edge lower; MD reappointed
Consolidated revenue dipped 0.8% and profit 3.4% for the year, while Q4 standalone profit fell 12.3% YoY. The board also reappointed the Vice-Chairman & MD for another five-year term.